"Cysteine Endopeptidases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
ENDOPEPTIDASES which have a cysteine involved in the catalytic process. This group of enzymes is inactivated by CYSTEINE PROTEINASE INHIBITORS such as CYSTATINS and SULFHYDRYL REAGENTS.
| Descriptor ID |
D003546
|
| MeSH Number(s) |
D08.811.277.656.262.500 D08.811.277.656.300.200
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Cysteine Endopeptidases".
Below are MeSH descriptors whose meaning is more specific than "Cysteine Endopeptidases".
This graph shows the total number of publications written about "Cysteine Endopeptidases" by people in this website by year, and whether "Cysteine Endopeptidases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 1 | 2 |
| 1996 | 0 | 1 | 1 |
| 1997 | 1 | 0 | 1 |
| 1998 | 3 | 1 | 4 |
| 1999 | 4 | 3 | 7 |
| 2000 | 0 | 3 | 3 |
| 2001 | 1 | 1 | 2 |
| 2002 | 5 | 3 | 8 |
| 2003 | 3 | 5 | 8 |
| 2004 | 6 | 6 | 12 |
| 2006 | 3 | 0 | 3 |
| 2007 | 2 | 2 | 4 |
| 2008 | 4 | 2 | 6 |
| 2009 | 3 | 0 | 3 |
| 2010 | 1 | 1 | 2 |
| 2011 | 2 | 0 | 2 |
| 2012 | 1 | 0 | 1 |
| 2013 | 1 | 2 | 3 |
| 2014 | 3 | 1 | 4 |
| 2015 | 2 | 0 | 2 |
| 2017 | 2 | 0 | 2 |
| 2018 | 0 | 1 | 1 |
| 2019 | 0 | 1 | 1 |
| 2020 | 0 | 1 | 1 |
| 2024 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cysteine Endopeptidases" by people in Profiles.
-
SERPINB7 Deficiency Increases Legumain Activity and Impairs the Epidermal Barrier in Nagashima-Type Palmoplantar Keratoderma. J Invest Dermatol. 2025 Feb; 145(2):359-369.e8.
-
Chagasin from Trypanosoma cruzi as a molecular scaffold to express epitopes of TSA-1 as soluble recombinant chimeras. Protein Expr Purif. 2024 Jun; 218:106458.
-
Functional map of SARS-CoV-2 3CL protease reveals tolerant and immutable sites. Cell Host Microbe. 2022 10 12; 30(10):1354-1362.e6.
-
E2F1 sumoylation as a protective cellular mechanism in oxidative stress response. Proc Natl Acad Sci U S A. 2020 06 30; 117(26):14958-14969.
-
The Epstein-Barr Virus Oncoprotein, LMP1, Regulates the Function of SENP2, a SUMO-protease. Sci Rep. 2019 07 02; 9(1):9523.
-
The deubiquitinase Otub1 controls the activation of CD8+ T cells and NK cells by regulating IL-15-mediated priming. Nat Immunol. 2019 07; 20(7):879-889.
-
The proteasome activator REG? counteracts immunoproteasome expression and autoimmunity. J Autoimmun. 2019 09; 103:102282.
-
Preventing abnormal NF-?B activation and autoimmunity by Otub1-mediated p100 stabilization. Cell Res. 2019 06; 29(6):474-485.
-
MAGI1 as a link between endothelial activation and ER stress drives atherosclerosis. JCI Insight. 2019 04 04; 4(7).
-
Structural Basis of Substrate Recognition and Covalent Inhibition of Cdu1 from Chlamydia trachomatis. ChemMedChem. 2018 10 08; 13(19):2014-2023.